Skip to main content
Equibles

READYSTATE ASSET MANAGEMENT LP

Position in AKTS — Aktis Oncology, Inc.

CIK 1900923 CHICAGO, IL
Back to AKTS Full portfolio

Position in AKTS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$966,900
+$430,200 QoQ
Shares Held
30,000
0.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

READYSTATE ASSET MANAGEMENT LP holds $170,733,904 across 15 Biotechnology names. AKTS ranks #13 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMNM
Immunome Inc.
 1,605,820 $34,027,325
2 ABVX
Abivax S.A.
 241,530 $32,186,287
3 WVE
Wave Life Sciences, Inc.
 4,727,139 $27,464,677
4 QURE
uniQure N.V.
 400,989 $18,469,553
5 VERA
Vera Therapeutics, Inc.
 295,114 $12,663,341
6 PCVX
Vaxcyte, Inc.
 156,090 $9,073,511
7 AXSM
Axsome Therapeutics, Inc.
 33,554 $8,213,012
8 OLMA
Olema Pharmaceuticals, Inc.
 593,829 $7,428,800

All Filings in AKTS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $966,900 30,000
2026-03-31 $536,700 30,000